IQ-AI Limited Issue of shares to Mayo Clinic (9343A)
February 08 2022 - 12:59AM
UK Regulatory
TIDMIQAI
RNS Number : 9343A
IQ-AI Limited
08 February 2022
8 February 2022
IQ-AI Ltd
("IQ-AI" or the "Company")
Issue of shares to Mayo Clinic
Further to the Company's announcement dated 9 November 2020,
IQ-AI announces the allotment of 113,781 ordinary shares of 1p each
in IQ-AI (the "New Ordinary Shares") to Mayo Clinic, at a price of
6.41p per share. The New Ordinary Shares were issued in accordance
with the research and collaboration agreement regarding IB Trax,
entered into between Mayo Clinic and Imaging Biometrics, LLC, a
subsidiary of IQ-AI.
Application will be made for the 113,781 New Ordinary Shares to
be admitted to the Official List of the UK Listing Authority by way
of a Standard Listing ("Admission") and it is expected that
Admission will become effective and that dealing in the New
Ordinary Shares will commence on or around 8 am on 11 February
2022. The New Ordinary Shares will rank pari passu with the
existing ordinary shares of the Company.
Following Admission, the Company will have 182,621,390 ordinary
shares of 1p each in issue, none of which are held in treasury.
Therefore, the total number of voting rights in the Company is
182,621,390.
The above figure of 182,621,390 may be used by shareholders in
the Company as the denominator for the calculations by which they
will determine if they are required to notify their interest in, or
a change in their interest in, the share capital of the Company
under the FCA's Disclosure and Transparency Rules.
The Directors of the Company accept responsibility for the
contents of this announcement
-ENDS-
For further information, please contact:
IQ-AI Limited
Trevor Brown/Brett Skelly/Vinod Kaushal
Tel: 020 7469 0930
Peterhouse Capital Limited (Financial Adviser and Broker)
Lucy Williams/Heena Karani
Tel: 020 7220 9797
Market Abuse Regulation (MAR) Disclosure
This announcement contains inside information for the purposes
of Article 7 of the Market Abuse Regulation EU 596/2014 as it forms
part of retained EU law (as defined in the European Union
(Withdrawal) Act 2018).
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
IOESSEFIWEESEDE
(END) Dow Jones Newswires
February 08, 2022 01:59 ET (06:59 GMT)
Iq-ai (LSE:IQAI)
Historical Stock Chart
From Apr 2024 to May 2024
Iq-ai (LSE:IQAI)
Historical Stock Chart
From May 2023 to May 2024